Smith & Nephew knee revisions
This article was originally published in The Gray Sheet
Executive Summary
Macrotextured knee implant revision surgeries total 295 as of April 30, the firm reports. S&N's voluntary August 2003 U.S. market withdrawal of cementless Oxinium Genesis II and Oxinium Profix total knee systems followed reports of implant loosening (1"The Gray Sheet" Sept. 22, 2003, p. 15). The firm "continue[s] to believe the withdrawal remains manageable," S&N says. Fiscal first quarter (ended April 3) knee sales growth of 24% and hip sales up 18% aided a 17% advance in orthopedic revenues. Sales advanced 9% to about $538 mil. for the quarter...